CD8 T cells are considered a favorable prognosis marker for several cancer types, including breast cancer (24, 25); worse outcomes are expected in patients with tumors poorly infiltrated by them, suggesting that obese patients might have disease progression sooner than non-obese, as we observed in our 4T1 mice model. Here, CD8A is linked to cancer.